The Lawyer’s newest product is the most comprehensive overview of the Asia-Pacific legal market yet produced. With rankings of the top 100 local law firms by lawyer headcount as well as analysis of the leading 50 international players in the region, it is essential reading for anyone interested in the strategic future of the world’s fastest growing legal market
US FIRMS are advising on the merger between pharmaceutical giants Pfizer and Warner-Lambert.
Both companies have instructed New York-based lawyers on the £51.2bn merger - one of the five biggest - which will create the world's second largest pharmaceuticals group.
Pfizer has instructed Cadwalader Wickersham & Taft and Kaye Scholer Fierman Hays & Handler. Warner-Lambert is using Skadden Arps Slate Meagher & Flom and Wachtell Lipton Rosen & Katz.
Linklaters corporate finance partner Stephen Boughton, the lead partner for SmithKline Beecham in its £114bn merger with Glaxo Wellcome, says: "The whole deal is a US company bidding for another US company. "
Victoria Kitcatt, senior legal adviser at Pfizer in the UK, says: "It's not a UK issue so nothing's happening over here at the moment.
"There might be some incidental work in the future for London generated by the merger."